Tradersweekly

PayPal added to the watchlist

NASDAQ:PYPL   PayPal Holdings, Inc.
Shares of PayPal lost nearly 82% of their value since the top in July 2021, and judging solely by this metric, one could consider the stock cheap. Nonetheless, there is more to it. In 2022, PayPal saw its revenue increase by 8% on a yearly basis and transaction volume grow by 16%. In addition to that, the company processed 22.3 billion payments and $1.36 trillion in total payment volume, with active accounts rising by 2% YoY to 435 million. However, its operating margin dropped by 10% and net income by 42% (using GAAP accounting).

In the first quarter of 2023, the company delivered better results compared to the first quarter of 2022, with net revenue growing 9% YoY, operating income by 41% YoY, earnings per share by 62% YoY, and net income by 56% YoY. As for the second quarter of 2023, the company reported a further increase in net revenues by 7% YoY, operating income by 48% YoY, and earnings per share by 414% YoY. In this quarter, PayPal generated $1.029 billion in net income compared to the loss of $341 million a year earlier.

Based on some of the fundamental improvements and cheap valuation, we think PayPal is growing increasingly attractive and worth watching out for. However, we would like to emphasize that the stock keeps making lower lows and lower highs. Thus, entering the trade is still quite risky. One alternative to approach this situation is to wait for a price to break above the upper bound of the channel and place a long entry there with stop-loss below the bound.

Illustration 1.01
Illustration 1.01 displays the daily chart of PayPal and its losses since the top in July 2021.

Technical analysis gauge
Daily time frame = Bearish
Weekly time frame = Bearish
*The gauge does not necessarily indicate where the market will head. Instead, it reflects the constellation of RSI, MACD, Stochastic, DM+-, ADX, and moving averages.

Please feel free to express your ideas and thoughts in the comment section.

DISCLAIMER: This analysis is not intended to encourage any buying or selling of any particular securities. Furthermore, it should not be a basis for taking any trade action by an individual investor. Therefore, your own due diligence is highly advised before entering a trade.


We just launched our own website!
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.